Home › Genabio Diagnostics Inc. › Genabio COVID-19 Rapid Self-Test Kit
Genabio COVID-19 Rapid Self-Test Kit
Genabio Diagnostics Inc. · Model N/A · UDI-DI 00810143620184
0
510(k) clearances
26,743
Adverse events (5 deaths)
47
Recalls
83
Facilities
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2025-01-24 | Guangzhou Pluslife Biotech Co., Ltd. | Devices were distributed in the U.S. market without obtaining the required FDA premarket authorization (e.g., 510(k) clearance or PMA). |
| 2025-01-24 | Guangzhou Pluslife Biotech Co., Ltd. | Devices were distributed in the U.S. market without obtaining the required FDA premarket authorization (e.g., 510(k) clearance or PMA). |
| 2023-03-31 | SD Biosensor, Inc. | The liquid buffer component in the affected test kit lots was determined to have bacterial contamination. User may notice a slight odor when the buffer is brought close to the nos |
| 2022-12-08 | Detect Headquarters | There is an increased chance that the tests from affected lots may give false negative results. Health risks resulting from a false negative result include delay or lack of support |
| 2022-11-28 | Universal Meditech Inc. | Distribution of SARS-CoV-2 Antigen Rapid Test Kits without FDA market approval, clearance or Emergency Use Authorization. |
| 2022-09-23 | LumiraDx | Assigned vial lot numbers for the incorrect type of product. SARS-CoV-2 & Flu A/B lot numbers were incorrectly assigned to the positive and negative vial lot numbers for SARS-CoV-2 |
| 2022-09-02 | LUMINOSTICS, INC dba CLIP HEALTH | COVID test kit shelf life was periodically extended, as real-time stability test timepoints passed, without FDA concurrence. |
| 2022-08-09 | Jiangsu Well Biotech Co.,Ltd. | Distribution of COVID-19 Ag Rapid Test kits in the U.S. without an Emergency Use Authorization, or a Pre-Market Approval or Clearance. |
| 2022-06-15 | North American Diagnostics | Various brands of SARS CoV 2 Antigen Rapid Test kits were offered for sale and distribution to consumers in the United States without marketing approval, clearance, or authorizati |
| 2022-04-09 | Woodside Acquisitions Inc. | Firm distributed tests which have not been cleared or authorized for marketing or distribution in the United States. |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.
